Abstract
Purpose To determine whether AMPA receptor (AMPAR) antagonist NBQX can prevent early mammalian target of rapamycin (mTOR) pathway activation and long-term sequelae following neonatal seizures in rats, including later-life spontaneous recurrent seizures, CA3 mossy fiber sprouting, and autistic-like social deficits. Methods Long-Evans rats experienced hypoxia-induced neonatal seizures (HS) at postnatal day (P)10. NBQX (20 mg/kg) was administered immediately following HS (every 12 h × 4 doses). Twelve hours post-HS, we assessed mTOR activation marker phosphorylated p70-S6 kinase (p-p70S6K) in hippocampus and cortex of vehicle (HS + V) or NBQX-treated post-HS rats (HS + N) versus littermate controls (C + V). Spontaneous seizure activity was compared between groups by epidural cortical electroencephalography (EEG) at P70-100. Aberrant mossy fiber sprouting was measured using Timm staining. Finally, we assessed behavior between P30 and P38. Key Findings Postseizure NBQX treatment significantly attenuated seizure-induced increases in p-p70S6K in the hippocampus (p < 0.01) and cortex (p < 0.001). Although spontaneous recurrent seizures increased in adulthood in HS + V rats compared to controls (3.22 ± 1 seizures/h; p = 0.03), NBQX significantly attenuated later-life seizures (0.14 ± 0.1 seizures/h; p = 0.046). HS + N rats showed less aberrant mossy fiber sprouting (115 ± 8.0%) than vehicle-treated post-HS rats (174 ± 10%, p = 0.004), compared to controls (normalized to 100%). Finally, NBQX treatment prevented alterations in later-life social behavior; post-HS rats showed significantly decreased preference for a novel over a familiar rat (71.0 ± 12 s) compared to controls (99.0 ± 15.6 s; p < 0.01), whereas HS + N rats showed social novelty preference similar to controls (114.3 ± 14.1 s). Significance Brief NBQX administration during the 48 h postseizure in P10 Long-Evans rats suppresses transient mTOR pathway activation and attenuates spontaneous recurrent seizures, social preference deficits, and mossy fiber sprouting observed in vehicle-treated adult rats after early life seizures. These results suggest that acute AMPAR antagonist treatment during the latent period immediately following neonatal HS can modify seizure-induced activation of mTOR, reduce the frequency of later-life seizures, and protect against CA3 mossy fiber sprouting and autistic-like social deficits.
Original language | American English |
---|---|
Journal | Epilepsia |
Volume | 54 |
State | Published - Jan 1 2013 |
Keywords
- 3 dione
- 6 nitro 7 sulfamoylbenzo[f]quinoxaline 2
- AMPA
- AMPA receptor antagonists
- Aging
- Animal
- Animals
- Autistic Disorder
- Autistic-like behavior
- Behavior
- Disease Models
- Early life seizures
- Epileptogenesis
- Hypoxic/ischemic encephalopathy
- Long Evans rat
- Long-Evans
- Neurons
- Newborn
- Quinoxalines
- Rats
- Receptors
- Seizures
- Western blotting
- animal cell
- animal experiment
- animal model
- article
- autistic like social deficit
- brain cortex
- brain enzyme
- controlled study
- electroencephalography
- hippocampal CA3 region
- hippocampus
- human
- human cell
- infantile spasm
- later life epileptic seizure
- male
- nonhuman
- p70S6 kinase
- postnatal growth
- priority journal
- protein phosphorylation
- rat
- seizure
- social behavior
- sprouting
- staining
- tonic clonic seizure
- unclassified drug
Disciplines
- Neuroscience and Neurobiology